Page last updated: 2024-08-26

sr141716 and gw 803430

sr141716 has been researched along with gw 803430 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahmad, S; Azzara, AV; Bisaha, S; Devenny, J; Flynn, N; Gemzik, B; Glick, S; Godonis, H; Harvey, S; Hernandez, AS; Huang, C; Janovitz, EB; Longhi, D; Murphy, BJ; Ngu, K; Pelleymounter, MA; Robl, JA; Rohrbach, K; Rooney, S; Thomas, M; Wang, W; Washburn, WN; Zhang, H; Zhang, L	1

Other Studies

1 other study(ies) available for sr141716 and gw 803430

Article	Year
Synthesis and Antiobesity Properties of 6-(4-Chlorophenyl)-3-(4-((3,3-difluoro-1-hydroxycyclobutyl)methoxy)-3-methoxyphenyl)thieno[3,2-d]pyrimidin-4(3H)-one (BMS-814580): A Highly Efficacious Melanin Concentrating Hormone Receptor 1 (MCHR1) Inhibitor. Journal of medicinal chemistry, 2016, 10-13, Volume: 59, Issue:19 Topics: Animals; Anti-Obesity Agents; Dogs; Halogenation; Humans; Macaca fascicularis; Male; Mice; Obesity; Pyrimidines; Rats; Receptors, Somatostatin; Structure-Activity Relationship	2016

Article

Year

Synthesis and Antiobesity Properties of 6-(4-Chlorophenyl)-3-(4-((3,3-difluoro-1-hydroxycyclobutyl)methoxy)-3-methoxyphenyl)thieno[3,2-d]pyrimidin-4(3H)-one (BMS-814580): A Highly Efficacious Melanin Concentrating Hormone Receptor 1 (MCHR1) Inhibitor.

Journal of medicinal chemistry, 2016, 10-13, Volume: 59, Issue:19

Topics: Animals; Anti-Obesity Agents; Dogs; Halogenation; Humans; Macaca fascicularis; Male; Mice; Obesity; Pyrimidines; Rats; Receptors, Somatostatin; Structure-Activity Relationship

2016